GM-CSFR alpha Antibody (009) [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-89610PCP
Recombinant Monoclonal Antibody
![Novus Antibodies Novus Antibodies](https://resources.rndsystems.com/categoryimages/novus_antibodies.jpg)
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Flow Cytometry
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 009
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was obtained from a rabbit immunized with purified, recombinant Human GM-CSFR alpha (Uniprot#: P15509-1; Met1-Gly320).
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for GM-CSFR alpha Antibody (009) [PerCP]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: GM-CSF R alpha
Long Name
Granulocyte Macrophage Growth Factor Receptor alpha
Alternate Names
CD116, CSF2R, CSF2RA, CSF2RY, GM-CSFRa, GMCSFR alpha
Gene Symbol
CSF2RA
Additional GM-CSF R alpha Products
Product Documents for GM-CSFR alpha Antibody (009) [PerCP]
Product Specific Notices for GM-CSFR alpha Antibody (009) [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...